Clinical Trial Update: A Study of QT and QTc Intervals in Patients Administered Extended Release Paliperidone or Quetiapine [Phase 1]

View source ↗

Summary

A Phase 1 study update assessing the effects of extended-release paliperidone and quetiapine on QT and QTc intervals in patients with schizophrenia or schizoaff…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Paliperidone Extended Release (paliperidone extended-release)
• Quetiapine (quetiapine)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 1 | Status: COMPLETED